124 related articles for article (PubMed ID: 10753189)
1. Role of MAP kinase signalling pathways in the mode of action of peroxisome proliferators.
Cosulich S; James N; Roberts R
Carcinogenesis; 2000 Apr; 21(4):579-84. PubMed ID: 10753189
[TBL] [Abstract][Full Text] [Related]
2. Role for tumor necrosis factor alpha receptor 1 and interleukin-1 receptor in the suppression of mouse hepatocyte apoptosis by the peroxisome proliferator nafenopin.
West DA; James NH; Cosulich SC; Holden PR; Brindle R; Rolfe M; Roberts RA
Hepatology; 1999 Dec; 30(6):1417-24. PubMed ID: 10573520
[TBL] [Abstract][Full Text] [Related]
3. Mouse hepatocyte response to peroxisome proliferators: dependency on hepatic nonparenchymal cells and peroxisome proliferator activated receptor alpha (PPARalpha).
Hasmall S; James N; Hedley K; Olsen K; Roberts R
Arch Toxicol; 2001 Aug; 75(6):357-61. PubMed ID: 11570693
[TBL] [Abstract][Full Text] [Related]
4. Role of hepatic non-parenchymal cells in the response of rat hepatocytes to the peroxisome proliferator nafenopin in vitro.
Hasmall SC; West DA; Olsen K; Roberts RA
Carcinogenesis; 2000 Dec; 21(12):2159-65. PubMed ID: 11133804
[TBL] [Abstract][Full Text] [Related]
5. Suppression of mouse hepatocyte apoptosis by peroxisome proliferators: role of PPARalpha and TNFalpha.
Hasmall SC; James NH; Macdonald N; Gonzalez FJ; Peters JM; Roberts RA
Mutat Res; 2000 Mar; 448(2):193-200. PubMed ID: 10725472
[TBL] [Abstract][Full Text] [Related]
6. A dominant negative form of IKK2 prevents suppression of apoptosis by the peroxisome proliferator nafenopin.
Cosulich SC; James NH; Needham MR; Newham PP; Bundell KR; Roberts RA
Carcinogenesis; 2000 Sep; 21(9):1757-60. PubMed ID: 10964109
[TBL] [Abstract][Full Text] [Related]
7. Induction of DNA replication by peroxisome proliferators is independent of both tumour necrosis factor (alpha) priming and EGF-receptor tyrosine kinase activity.
Chevalier S; Macdonald N; Roberts RA
J Cell Sci; 1999 Dec; 112 ( Pt 24)():4785-91. PubMed ID: 10574725
[TBL] [Abstract][Full Text] [Related]
8. Tumour necrosis factor alpha (TNFalpha): role in suppression of apoptosis by the peroxisome proliferator nafenopin.
Holden PR; Hasmall SC; James NH; West DR; Brindle RD; Gonzalez FJ; Peters JM; Roberts RA
Cell Mol Biol (Noisy-le-grand); 2000 Feb; 46(1):29-39. PubMed ID: 10726969
[TBL] [Abstract][Full Text] [Related]
9. Species differences in response to peroxisome proliferators correlate in vitro with induction of DNA synthesis rather than suppression of apoptosis.
James NH; Roberts RA
Carcinogenesis; 1996 Aug; 17(8):1623-32. PubMed ID: 8761418
[TBL] [Abstract][Full Text] [Related]
10. The peroxisome proliferator nafenopin does not suppress hepatocyte apoptosis in guinea-pig liver in vivo nor in human hepatocytes in vitro.
Hasmall SC; James NH; Soames AR; Roberts RA
Arch Toxicol; 1998 Dec; 72(12):777-83. PubMed ID: 9950074
[TBL] [Abstract][Full Text] [Related]
11. Proteomic analysis of differential protein expression in primary hepatocytes induced by EGF, tumour necrosis factor alpha or the peroxisome proliferator nafenopin.
Chevalier S; Macdonald N; Tonge R; Rayner S; Rowlinson R; Shaw J; Young J; Davison M; Roberts RA
Eur J Biochem; 2000 Aug; 267(15):4624-34. PubMed ID: 10903494
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the effects of various peroxisome proliferators on peroxisomal enzyme activities, DNA synthesis, and apoptosis in rat and human hepatocyte cultures.
Goll V; Alexandre E; Viollon-Abadie C; Nicod L; Jaeck D; Richert L
Toxicol Appl Pharmacol; 1999 Oct; 160(1):21-32. PubMed ID: 10502499
[TBL] [Abstract][Full Text] [Related]
13. Addition of peroxisome proliferator-activated receptor alpha to guinea pig hepatocytes confers increased responsiveness to peroxisome proliferators.
Macdonald N; Holden PR; Roberts RA
Cancer Res; 1999 Oct; 59(19):4776-80. PubMed ID: 10519382
[TBL] [Abstract][Full Text] [Related]
14. Tumour necrosis factor alpha (TNF alpha) suppresses apoptosis and induces DNA synthesis in rodent hepatocytes: a mediator of the hepatocarcinogenicity of peroxisome proliferators?
Rolfe M; James NH; Roberts RA
Carcinogenesis; 1997 Nov; 18(11):2277-80. PubMed ID: 9395232
[TBL] [Abstract][Full Text] [Related]
15. Reduced expression of mature TGF beta 1 correlates with the suppression of rat hepatocyte apoptosis by the peroxisome proliferator, nafenopin.
Strange J; Roberts RA
Mutat Res; 1996 Nov; 372(1):107-13. PubMed ID: 9003537
[TBL] [Abstract][Full Text] [Related]
16. The rodent non-genotoxic hepatocarcinogen nafenopin suppresses apoptosis preferentially in non-cycling hepatocytes but also elevates CDK4, a cell cycle progression factor.
Gill JH; Brickell P; Dive C; Roberts RA
Carcinogenesis; 1998 Oct; 19(10):1743-7. PubMed ID: 9806153
[TBL] [Abstract][Full Text] [Related]
17. The non-genotoxic hepatocarcinogen nafenopin suppresses rodent hepatocyte apoptosis induced by TGFbeta1, DNA damage and Fas.
Gill JH; James NH; Roberts RA; Dive C
Carcinogenesis; 1998 Feb; 19(2):299-304. PubMed ID: 9498280
[TBL] [Abstract][Full Text] [Related]
18. Peroxisome proliferator-activated receptor (PPAR) alpha-regulated growth responses and their importance to hepatocarcinogenesis.
James NH; Gill JH; Brindle R; Woodyatt NJ; Macdonald N; Rolfe M; Hasmall SC; Tugwood JD; Holden PR; Roberts RA
Toxicol Lett; 1998 Dec; 102-103():91-6. PubMed ID: 10022238
[TBL] [Abstract][Full Text] [Related]
19. Species differences in response to diethylhexylphthalate: suppression of apoptosis, induction of DNA synthesis and peroxisome proliferator activated receptor alpha-mediated gene expression.
Hasmall SC; James NH; Macdonald N; Soames AR; Roberts RA
Arch Toxicol; 2000 Apr; 74(2):85-91. PubMed ID: 10839475
[TBL] [Abstract][Full Text] [Related]
20. Peroxisome proliferators do not increase DNA synthesis in purified rat hepatocytes.
Parzefall W; Berger W; Kainzbauer E; Teufelhofer O; Schulte-Hermann R; Thurman RG
Carcinogenesis; 2001 Mar; 22(3):519-23. PubMed ID: 11238195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
